NCT04810793 - The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure | Biotech Hunter

Enrollment

820

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

June 1, 2022

Study Completion Date

June 30, 2022

Conditions

Helicobacter Pylori

Interventions

DRUG

Amoxicillin , Levofloxacin and Esomeprazole

Esomeprazole-Bismuth-Amoxicillin-Levofloxacin-containing quadruple regimens

DRUG

Amoxicillin , Furazolidone and Esomeprazole

Esomeprazole-Bismuth-Amoxicillin-Furazolidone-containing quadruple regimens

DRUG

Tetracycline , Furazolidone and Esomeprazole

Esomeprazole-Bismuth-Tetracycline-Furazolidone-containing quadruple regimens

DRUG

Amoxicillin,Levofloxacin and Vonoprazan fumarate

Amoxicillin-Levofloxacin-Vonoprazan fumarate-containing quadruple group

DRUG

Amoxicillin,Furazolidone and Vonoprazan fumarate

Amoxicillin-Furazolidone-Vonoprazan fumarate-containing quadruple group

DRUG

Tetracycline,Furazolidone and Vonoprazan fumarate

Tetracycline-Furazolidone-Vonoprazan fumarate-containing quadruple group

Trial Locations (1)

257000

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors

collaborator

Taian City Central Hospital

OTHER

collaborator

Dezhou People's Hospital

OTHER

collaborator

Weifang Medical University

OTHER

collaborator

The Affiliated Hospital of Qingdao University

OTHER

collaborator

Shengli Oilfield Hospital

OTHER

lead

Shandong University

OTHER